Epicast Report: Head and Neck Cancers - Epidemiology Forecast to 2024

Submitted by: Submitted by

Views: 10

Words: 845

Pages: 4

Category: Business and Industry

Date Submitted: 02/27/2016 12:21 AM

Report This Essay

Bharat Book Bureau provides the report, on “EpiCast Report: Head and Neck Cancers - Epidemiology Forecast to 2024". https://www.bharatbook.com/healthcare-market-research-reports-751499/epicast-report-head-neck-cancers.html

27th, Feb., 2016, Mumbai, India: Bharatbook.com announces a report on “EpiCast Report: Head and Neck Cancers - Epidemiology Forecast to 2024". The HNCs EpiCast report will allow you to Develop business strategies by understanding the trends shaping and driving the global HNCs market.

Summary

Head and neck cancers (HNCs) are a heterogeneous group, consisting of cancers of the mouth, including the lip, tongue, gum, floor of mouth, palate, and other parts of mouth; the salivary glands; the pharynx, including the tonsil, oropharynx, nasopharynx, pyriform fossa, hypopharynx, other mouth/pharynx; the nose, sinuses, and related structures; the larynx; and the thyroid. HNCs usually begin in the squamous cells that line the moist mucosal surfaces of the tissues and organs of the head and neck — more than 80% of all HNCs are squamous cell carcinomas. HNCs are common in several regions across the globe and account for 600,000 new cases annually worldwide.

Epidemiologists forecast an increase in diagnosed incident cases of HNCs in the 7MM from 151,393 diagnosed incident cases in 2014 to 174,056 diagnosed incident cases in 2024, with an Annual Growth Rate (AGR) of 1.50% during the forecast period. In 2024, the US will have the highest number of diagnosed incident cases of HNCs in the 7MM, with 65,663 diagnosed incident cases, whereas the UK will have the lowest number of diagnosed incident cases of HNCs, with 12,702 diagnosed incident cases in 2024. The diagnosed incident cases of thyroid cancer in the 7MM are expected to increase from 93,225 diagnosed incident cases in 2014 to 123,504 diagnosed incident cases in 2024, with an AGR of 3.25% during the forecast period. In 2024, the US will have the highest number of diagnosed incident cases of thyroid...